Cloud P Paweletz

Cloud P Paweletz

UNVERIFIED PROFILE

Are you Cloud P Paweletz?   Register this Author

Register author
Cloud P Paweletz

Cloud P Paweletz

Publications by authors named "Cloud P Paweletz"

Are you Cloud P Paweletz?   Register this Author

58Publications

1906Reads

28Profile Views

Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.

Lung Cancer 2019 Aug 5;134:96-99. Epub 2019 Jun 5.

Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, 360 Longwood Avenue, Boston, MA, 02215, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.06.004DOI Listing
August 2019

Salivary HPV DNA informs locoregional disease status in advanced HPV-associated oropharyngeal cancer.

Oral Oncol 2019 Aug 20;95:120-126. Epub 2019 Jun 20.

Robert and Renée Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2019.06.019DOI Listing
August 2019

Monitoring of Response and Resistance in Plasma of EGFR-Mutant Lung Cancer Using Droplet Digital PCR.

Methods Mol Biol 2018 ;1768:193-207

Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-7778-9_12DOI Listing
February 2019

Regarding the Congruence Between 2 Circulating Tumor DNA Sequencing Assays.

JAMA Oncol 2018 Oct;4(10):1428-1429

Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2018.2311DOI Listing
October 2018

False-Positive Plasma Genotyping Due to Clonal Hematopoiesis.

Clin Cancer Res 2018 09 22;24(18):4437-4443. Epub 2018 Mar 22.

Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/lookup/doi/10.1158/107
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-18-0143DOI Listing
September 2018

Liquid biopsy of fine-needle aspiration supernatant for lung cancer genotyping.

Lung Cancer 2018 08 25;122:72-75. Epub 2018 May 25.

Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2018.05.024DOI Listing
August 2018

Cell-Free DNA in Oncology: Gearing up for Clinic.

Ann Lab Med 2018 Jan;38(1):1-8

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3343/alm.2018.38.1.1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5700141PMC
January 2018

Genomic Analysis of Plasma Cell-Free DNA in Patients With Cancer.

JAMA Oncol 2017 06;3(6):740-741

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts5Center for Advanced Molecular Diagnostics, Brigham and Women's Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.2835DOI Listing
June 2017

Association Between Plasma Genotyping and Outcomes of Treatment With Osimertinib (AZD9291) in Advanced Non-Small-Cell Lung Cancer.

J Clin Oncol 2016 10 27;34(28):3375-82. Epub 2016 Jun 27.

Geoffrey R. Oxnard, Ryan S. Alden, Cloud P. Paweletz, and Pasi A. Jänne, Dana-Farber Cancer Institute, Boston; Kenneth S. Thress and J. Carl Barrett, AstraZeneca, Waltham, MA; Rachael Lawrance and Mireille Cantarini, AstraZeneca, Macclesfield, United Kingdom; and James Chih-Hsin Yang, National Taiwan University and National Taiwan University Hospital, Taipei, Taiwan.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035123PMC
http://dx.doi.org/10.1200/JCO.2016.66.7162DOI Listing
October 2016

Monitoring cancer through the blood.

Cancer 2014 Dec 7;120(24):3859-61. Epub 2014 Aug 7.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.28967DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791955PMC
December 2014

Realizing the potential of plasma genotyping in an age of genotype-directed therapies.

J Natl Cancer Inst 2014 Aug 8;106(8). Epub 2014 Aug 8.

Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA (JJL, GRO, CPP, BEJ), Memorial Sloan-Kettering Cancer Center, New York, NY (DBS), University of Colorado Cancer Center, Denver, CO (DRC); The University of Texas MD Anderson Cancer Center, Houston, TX (JVH).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6281080PMC
August 2014

Protein microarray platforms for clinical proteomics.

Proteomics Clin Appl 2007 Sep 10;1(9):934-52. Epub 2007 Aug 10.

Department of Anatomy, Physiology and Genetics, Uniformed Services University School of Medicine, USUHS, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/prca.200700154DOI Listing
September 2007

Quantitative analysis of complex peptide mixtures using FTMS and differential mass spectrometry.

J Am Soc Mass Spectrom 2007 Feb 25;18(2):226-33. Epub 2006 Oct 25.

Molecular Profiling Proteomics, Merck Research Laboratories, Merck and Co. Inc., Rahway, New Jersey 07065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jasms.2006.09.014DOI Listing
February 2007

Proteomic analysis of human bladder tissue using SELDI approach following microdissection techniques.

Methods Mol Biol 2005 ;293:255-67

Institute of Pathology, University of Hospital Aachen, RWTH, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1385/1-59259-853-6:255DOI Listing
June 2006

Surface enhanced laser desorption ionization spectrometry reveals biomarkers for drug treatment but not dose.

Proteomics 2006 Apr;6(7):2101-7

Department of Molecular Profiling Proteomics, Merck Research Laboratories, Rahway, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200500569DOI Listing
April 2006

Identification and characterization of SSTK, a serine/threonine protein kinase essential for male fertility.

Mol Cell Biol 2005 May;25(10):4250-61

Division of Therapeutic Proteins, Center for Drug Evaluation and Research, Food and Drug Administration, HFD-122, Bldg. 29A, Rm. 3B-20, 8800 Rockville Pike, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://mcb.asm.org/cgi/doi/10.1128/MCB.25.10.4250-4261.2005
Publisher Site
http://dx.doi.org/10.1128/MCB.25.10.4250-4261.2005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1087724PMC
May 2005

Proteomic approaches to the diagnosis, treatment, and monitoring of cancer.

Adv Exp Med Biol 2003 ;532:59-68

FDA/NCI Clinical Proteomics Program, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4615-0081-0_7DOI Listing
February 2004

Dilution of protein gel stain results in retention of staining capacity.

Biotechniques 2003 Aug;35(2):376-8

Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2144/03352pt01DOI Listing
August 2003

Serum-derived protein S binds to phosphatidylserine and stimulates the phagocytosis of apoptotic cells.

Nat Immunol 2003 Jan 25;4(1):87-91. Epub 2002 Nov 25.

Laboratory of Biochemistry, Division of Therapeutic Proteins, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ni871DOI Listing
January 2003

Proteomic technologies to study diseases of the lymphatic vascular system.

Ann N Y Acad Sci 2002 Dec;979:211-28; discussion 229-34

Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1749-6632.2002.tb04881.xDOI Listing
December 2002

Serum proteomic patterns for detection of prostate cancer.

J Natl Cancer Inst 2002 Oct;94(20):1576-8

Food and Drug Administration (FDA)-National Cancer Institute (NCI) Clinical Proteomics Program, Department of Therapeutic Proteins/Center for Biologics Evaluation and Research (CBER), Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/94.20.1576DOI Listing
October 2002

Clinical applications of proteomics: proteomic pattern diagnostics.

J Mammary Gland Biol Neoplasia 2002 Oct;7(4):433-40

FDA-NCI Clinical Proteomics Program, Division of Therapeutic Proteins, Center for Biologic Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
October 2002

Utility of reverse phase protein arrays: applications to signalling pathways and human body arrays.

Brief Funct Genomic Proteomic 2002 Oct;1(3):305-15

Laser Capture Microdissection Core Facility, and Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/bfgp/1.3.305DOI Listing
October 2002

Clinical proteomics for cancer biomarker discovery and therapeutic targeting.

Technol Cancer Res Treat 2002 Aug;1(4):263-72

FDA-NCI Clinical Proteomics Program, Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/153303460200100407
Publisher Site
http://dx.doi.org/10.1177/153303460200100407DOI Listing
August 2002